Search

Your search keyword '"Glaudemans, Andor W.J.M."' showing total 368 results
Start Over Author "Glaudemans, Andor W.J.M."
368 results on '"Glaudemans, Andor W.J.M."'

6. [15O]H2O PET: Potential or Essential for Molecular Imaging?

Author

Slart, Riemer H.J.A., Martinez-Lucio, T. Samara, Boersma, Hendrikus H., Borra, Ronald H., Cornelissen, Bart, Dierckx, Rudi A.J.O., Dobrolinska, Magdalena, Doorduin, Janine, Erba, Paola A., Glaudemans, Andor W.J.M., Giacobbo, Bruno Lima, Luurtsema, Gert, Noordzij, Walter, van Sluis, Joyce, Tsoumpas, Charalampos, and Lammertsma, Adriaan A.

Published
2024
Full Text
View/download PDF

9. Infective Native Aortic Aneurysm: a Delphi Consensus Document on Treatment, Follow Up, and Definition of Cure

Author

Adam, Donald, Assadian, Ojan, Beck, Adam W., Berard, Xavier, Boutoille, David, Budtz-Lilly, Jacob, Chakfé, Nabil, Clough, Rachel E., Czerny, Martin, Dang, Michael, D’Oria, Mario, Eldrup, Nikolaj, Fourneau, Inge, Gheysens, Olivier, Glaudemans, Andor W.J.M., Hasse, Barbara, Heinola, Ivika, Henckaerts, Liesbet, Hosaka, Akihiro, Huang, Yao-Kuang, Husmann, Lars, Jutidamrongphan, Warissara, Kakkos, Stavros, Kan, Chung-Dann, Kölbel, Tilo, Lau, Christopher, Lauri, Chiara, Lawaetz, Martin, Ljungquist, Oskar, Lyons, Oliver, Maciej, Juszczak, Mani, Kevin, Moulakakis, Konstantinos, Oderich, Gustavo S., Resch, Timothy, Schmidli, Jürg, Sedivy, Petr, Senneville, Eric, Shirasu, Takuro, Skov, Rebecca Andrea Conradsen, Slart, Riemer H.J.A., Szeberin, Zoltan, Touma, Joseph, van den Berg, Jos C., Veger, Hugo T.C., Wanhainen, Anders, Weiss, Salome, Wyss, Thomas R., Giardini, Matteo, and Sörelius, Karl

Published
2024
Full Text
View/download PDF

12. Positron Emission Tomography Imaging in Vasculitis

Author

van der Geest, Kornelis S.M., Slijkhuis, Berend G.C., Tomelleri, Alessandro, Gheysens, Olivier, Jiemy, William F., Piccolo, Costanza, Nienhuis, Pieter, Sandovici, Maria, Brouwer, Elisabeth, Glaudemans, Andor W.J.M., Mulder, Douwe J., and Slart, Riemer H.J.A.

Published
2023
Full Text
View/download PDF

16. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

Author

Dorbala, SHARMILA, ANDO, YUKIO, BOKHARI, SABAHAT, DISPENZIERI, ANGELA, FALK, RODNEY H., FERRARI, VICTOR A., FONTANA, MARIANNA, GHEYSENS, OLIVIER, GILLMORE, JULIAN D., GLAUDEMANS, ANDOR W.J.M., HANNA, MAZEN A., HAZENBERG, BOUKE P.C., KRISTEN, ARNT V., KWONG, RAYMOND Y., MAURER, MATHEW S., MERLINI, GIAMPAOLO, MILLER, EDWARD J., MOON, JAMES C., MURTHY, VENKATESH L., QUARTA, C. CRISTINA, RAPEZZI, CLAUDIO, RUBERG, FREDERICK L., SHAH, SANJIV J., SLART, RIEMER H.J.A., VERBERNE, HEIN J., and BOURQUE, JAMIESON M.

Published
2022
Full Text
View/download PDF

18. Prevalence of wild‐type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo‐VIP‐HF study

Author

Tubben, Alwin, primary, Tingen, Hendrea S.A., additional, Prakken, Niek H.J., additional, van Empel, Vanessa P.M., additional, Gorter, Thomas M., additional, Meems, Laura M.G., additional, Manintveld, Olivier C., additional, Rienstra, Michiel, additional, Tieleman, Robert G., additional, Glaudemans, Andor W.J.M., additional, van Veldhuisen, Dirk J., additional, Slart, Riemer H.J.A., additional, Nienhuis, Hans L.A., additional, and van der Meer, Peter, additional

Published
2024
Full Text
View/download PDF

21. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging

Author

Dorbala, Sharmila, Ando, Yukio, Bokhari, Sabahat, Dispenzieri, Angela, Falk, Rodney H., Ferrari, Victor A., Fontana, Marianna, Gheysens, Olivier, Gillmore, Julian D., Glaudemans, Andor W.J.M., Hanna, Mazen A., Hazenberg, Bouke P.C., Kristen, Arnt V., Kwong, Raymond Y., Maurer, Mathew S., Merlini, Giampaolo, Miller, Edward J., Moon, James C., Murthy, Venkatesh L., Quarta, C. Cristina, Rapezzi, Claudio, Ruberg, Frederick L., Shah, Sanjiv J., Slart, Riemer H.J.A., Verberne, Hein J., and Bourque, Jamieson M.

Published
2021
Full Text
View/download PDF

23. Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

Author

Boers, Jorianne, Eisses, Bertha, Zwager, Mieke C., van Geel, Jasper J.L., Bensch, Frederike, de Vries, Erik F.J., Hospers, Geke A.P., Glaudemans, Andor W.J.M., Brouwers, Adrienne H., den Dekker, Martijn A.M., Elias, Sjoerd G., Kuip, Evelien J.M., van Herpen, Carla M.L., Jager, Agnes, van der Veldt, Astrid A.M., Oprea-Lager, Daniela E., de Vries, Elisabeth G.E., van der Vegt, Bert, Menke-van der Houven van Oordt, Willemien C., Schröder, Carolina P., Boers, Jorianne, Eisses, Bertha, Zwager, Mieke C., van Geel, Jasper J.L., Bensch, Frederike, de Vries, Erik F.J., Hospers, Geke A.P., Glaudemans, Andor W.J.M., Brouwers, Adrienne H., den Dekker, Martijn A.M., Elias, Sjoerd G., Kuip, Evelien J.M., van Herpen, Carla M.L., Jager, Agnes, van der Veldt, Astrid A.M., Oprea-Lager, Daniela E., de Vries, Elisabeth G.E., van der Vegt, Bert, Menke-van der Houven van Oordt, Willemien C., and Schröder, Carolina P.

Abstract

Background: In metastatic breast cancer (MBC), [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) can be used for staging. We evaluated the correlation between BC histopathological characteristics and [18F]FDG uptake in corresponding metastases. Patients and Methods: Patients with non-rapidly progressive MBC of all subtypes prospectively underwent a baseline histological metastasis biopsy and [18F]FDG-PET. Biopsies were assessed for estrogen, progesterone, and human epidermal growth factor receptor 2 (ER, PR, HER2); Ki-67; and histological subtype. [18F]FDG uptake was expressed as maximum standardized uptake value (SUVmax) and results were expressed as geometric means. Results: Of 200 patients, 188 had evaluable metastasis biopsies, and 182 of these contained tumor. HER2 positivity and Ki-67 ≥ 20% were correlated with higher [18F]FDG uptake (estimated geometric mean SUVmax 10.0 and 8.8, respectively; p = 0.0064 and p = 0.014). [18F]FDG uptake was lowest in ER-positive/HER2-negative BC and highest in HER2-positive BC (geometric mean SUVmax 6.8 and 10.0, respectively; p = 0.0058). Although [18F]FDG uptake was lower in invasive lobular carcinoma (n = 31) than invasive carcinoma NST (n = 146) (estimated geometric mean SUVmax 5.8 versus 7.8; p = 0.014), the metastasis detection rate was similar. Conclusions:[18F]FDG-PET is a powerful tool to detect metastases, including invasive lobular carcinoma. Although BC histopathological characteristics are related to [18F]FDG uptake, [18F]FDG-PET and biopsy remain complementary in MBC staging (NCT01957332).

Published
2024

25. EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin.

Author

Hess, Søren, Noriega-Álvarez, Edel, Leccisotti, Lucia, Treglia, Giorgio, Albano, Domenico, Roivainen, Anne, Glaudemans, Andor W.J.M., and Gheysens, Olivier

Subjects
FEVER, POSITRON emission tomography, INFLAMMATION, MEDICAL specialties & specialists, COMPUTED tomography, SYMPTOMS, DOCUMENT imaging systems
Abstract

Purpose: Patients with fever and inflammation of unknown origin (FUO/IUO) are clinically challenging due to variable clinical presentations with nonspecific symptoms and many differential diagnoses. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is increasingly used in FUO and IUO, but the optimal diagnostic strategy remains controversial. This consensus document aims to assist clinicians and nuclear medicine specialists in the appropriate use of [18F]FDG-PET/CT in FUO and IUO based on current evidence. Methods: A working group created by the EANM infection and inflammation committee performed a systematic literature search based on PICOs with "patients with FUO/IUO" as population, "[18F]FDG-PET/CT" as intervention, and several outcomes including pre-scan characteristics, scan protocol, diagnostic yield, impact on management, prognosis, and cost-effectiveness. Results: We included 68 articles published from 2001 to 2023: 9 systematic reviews, 49 original papers on general adult populations, and 10 original papers on specific populations. All papers were analysed and included in the evidence-based recommendations. Conclusion: FUO and IUO remains a clinical challenge and [18F]FDG PET/CT has a definite role in the diagnostic pathway with an overall diagnostic yield or helpfulness in 50–60% of patients. A positive scan is often contributory by directly guiding treatment or subsequent diagnostic procedure. However, a negative scan may be equally important by excluding focal disease and predicting a favorable prognosis. Similar results are obtained in specific populations such as ICU-patients, children and HIV-patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

28. Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections

Author

Chakfé, Nabil, Diener, Holger, Lejay, Anne, Assadian, Ojan, Berard, Xavier, Caillon, Jocelyne, Fourneau, Inge, Glaudemans, Andor W.J.M., Koncar, Igor, Lindholt, Jes, Melissano, Germano, Saleem, Ben R., Senneville, Eric, Slart, Riemer H.J.A., Szeberin, Zoltan, Venermo, Maarit, Vermassen, Frank, Wyss, Thomas R., ESVS Guidelines Committee, de Borst, Gert J., Bastos Gonçalves, Frederico, Kakkos, Stavros K., Kolh, Philippe, Tulamo, Riikka, Vega de Ceniga, Melina, Document Reviewers, von Allmen, Regula S., van den Berg, Jos C., Debus, E. Sebastian, Koelemay, Mark J.W., Linares-Palomino, Jose P., Moneta, Gregory L., Ricco, Jean-Baptiste, and Wanhainen, Anders

Published
2020
Full Text
View/download PDF

30. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

Author

Dorbala, Sharmila, Ando, Yukio, Bokhari, Sabahat, Dispenzieri, Angela, Falk, Rodney H., Ferrari, Victor A., Fontana, Marianna, Gheysens, Olivier, Gillmore, Julian D., Glaudemans, Andor W.J.M., Hanna, Mazen A., Hazenberg, Bouke P.C., Kristen, Arnt V., Kwong, Raymond Y., Maurer, Mathew S., Merlini, Giampaolo, Miller, Edward J., Moon, James C., Murthy, Venkatesh L., Quarta, C. Cristina, Rapezzi, Claudio, Ruberg, Frederick L., Shah, Sanjiv J., Slart, Riemer H.J.A., Verberne, Hein J., and Bourque, Jamieson M.

Published
2019
Full Text
View/download PDF

31. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization

Author

Dorbala, Sharmila, Ando, Yukio, Bokhari, Sabahat, Dispenzieri, Angela, Falk, Rodney H., Ferrari, Victor A., Fontana, Marianna, Gheysens, Olivier, Gillmore, Julian D., Glaudemans, Andor W.J.M., Hanna, Mazen A., Hazenberg, Bouke P.C., Kristen, Arnt V., Kwong, Raymond Y., Maurer, Mathew S., Merlini, Giampaolo, Miller, Edward J., Moon, James C., Murthy, Venkatesh L., Quarta, C.Cristina, Rapezzi, Claudio, Ruberg, Frederick L., Shah, Sanjiv J., Slart, Riemer H.J.A., Verberne, Hein J., and Bourque, Jamieson M.

Published
2019
Full Text
View/download PDF

34. The first international network symposium on artificial intelligence and informatics in nuclear medicine: “The bright future of nuclear medicine is illuminated by artificial intelligence”

Author

Glaudemans, Andor W.J.M., primary, Dierckx, Rudi A.J.O., additional, Scheerder, Bart, additional, Niessen, Wiro J., additional, Pruim, Jan, additional, Dewi, Dyah E. O., additional, Borra, Ronald J.H., additional, Lammertsma, Adriaan A., additional, Tsoumpas, Charalampos, additional, and Slart, Riemer H.J.A., additional

Published
2023
Full Text
View/download PDF

36. The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine

Author

Tingen, Hendrea Sanne Aletta, primary, van Praagh, Gijs D., additional, Nienhuis, Pieter H., additional, Tubben, Alwin, additional, van Rijsewijk, Nick D., additional, ten Hove, Derk, additional, Mushari, Nouf A., additional, Martinez-Lucio, T. Samara, additional, Mendoza-Ibañez, Oscar I., additional, van Sluis, Joyce, additional, Tsoumpas, Charalampos, additional, Glaudemans, Andor W.J.M., additional, and Slart, Riemer H.J.A., additional

Published
2023
Full Text
View/download PDF

37. Role of 18F-FDG PET/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica

Author

Slart, Riemer H.J.A., Nienhuis, Pieter H., Glaudemans, Andor W.J.M., Brouwer, Elisabeth, Gheysens, Olivier, van der Geest, Kornelis S.M., ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Translational Immunology Groningen (TRIGR), Cardiovascular Centre (CVC), and Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI)

Subjects
F-FDG PET/CT, cranial GCA, large vessel vasculitis, PMR, Radiology, Nuclear Medicine and imaging, procedures
Abstract

Systemic vasculitides comprise a group of autoimmune diseases affecting blood vessels, including large vessel vasculitis (LVV) and medium-sized vessel vasculitis such as giant cell arteritis (GCA) and Takayasu arteritis (TAK). GCA frequently overlaps with polymyalgia rheumatica (PMR), a rheumatic inflammatory condition affecting bursae, tendons or tendon sheaths, and joints. 18F-FDG PET/CT plays an important role in the diagnostic work-up of GCA, PMR, and TAK and is increasingly used to monitor treatment response. This continuing education article provides up-to-date guidance on the role of 18F-FDG PET/CT in patients with LVV, medium-sized vessel vasculitis, and PMR. It provides a general introduction on the clinical presentation and challenges in the diagnostic work-up of LVV and medium-sized vessel vasculitis, with a focus on the 2 major LVV subtypes: GCA, including PMR, and TAK. Next, practice points to perform and interpret the results of 18F-FDG PET/CT are described in line with the published procedure recommendations. Furthermore, the diagnostic performance and its role for treatment monitoring are discussed, taking into account recent international recommendations for the use of imaging in LVV and medium-sized vessel vasculitis in clinical practice. This is illustrated by several clinically representative PET/CT scan examples. Lastly, knowledge of limitations and pitfalls is essential to understand the role of 18F-FDG PET/CT in LVV, medium-sized vessel vasculitis, and PMR. Challenges and opportunities, as well as future research and conclusions, are highlighted. Learning objectives provide up-to-date guidance for the role of 18F-FDG PET/CT in patients with suspected LVV, medium-sized vessel vasculitis, and PMR.

Published
2023

39. Tuberculosis

Author

Ankrah, Alfred O., Glaudemans, Andor W.J.M., Maes, Alex, Van de Wiele, Christophe, Dierckx, Rudi A.J.O., Vorster, Mariza, and Sathekge, Mike M.

Published
2018
Full Text
View/download PDF

40. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for89Zr-Trastuzumab

Author

Mohr, Philipp, primary, van Sluis, Joyce, additional, Providência, Laura, additional, van Snick, Johannes H., additional, Lub-de Hooge, Marjolijn N., additional, Willemsen, Antoon T., additional, Glaudemans, Andor W.J.M., additional, Boellaard, Ronald, additional, Lammertsma, Adriaan A., additional, Brouwers, Adrienne H., additional, and Tsoumpas, Charalampos, additional

Published
2023
Full Text
View/download PDF

43. Supplementary Table S3 from [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Author

Iqbal, Ramsha, primary, Yaqub, Maqsood, primary, Bektas, Huseyyin O., primary, Oprea-Lager, Daniela E., primary, de Vries, Elisabeth G.E., primary, Glaudemans, Andor W.J.M., primary, Aftimos, Philippe, primary, Gebhart, Géraldine, primary, Beelen, Andrew P., primary, Schuit, Robert C., primary, Windhorst, Albert D., primary, Boellaard, Ronald, primary, and Menke-van der Houven van Oordt, C. Willemien, primary

Published
2023
Full Text
View/download PDF

44. Data from [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Author

Iqbal, Ramsha, primary, Yaqub, Maqsood, primary, Bektas, Huseyyin O., primary, Oprea-Lager, Daniela E., primary, de Vries, Elisabeth G.E., primary, Glaudemans, Andor W.J.M., primary, Aftimos, Philippe, primary, Gebhart, Géraldine, primary, Beelen, Andrew P., primary, Schuit, Robert C., primary, Windhorst, Albert D., primary, Boellaard, Ronald, primary, and Menke-van der Houven van Oordt, C. Willemien, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure S3 from [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Author

Iqbal, Ramsha, primary, Yaqub, Maqsood, primary, Bektas, Huseyyin O., primary, Oprea-Lager, Daniela E., primary, de Vries, Elisabeth G.E., primary, Glaudemans, Andor W.J.M., primary, Aftimos, Philippe, primary, Gebhart, Géraldine, primary, Beelen, Andrew P., primary, Schuit, Robert C., primary, Windhorst, Albert D., primary, Boellaard, Ronald, primary, and Menke-van der Houven van Oordt, C. Willemien, primary

Published
2023
Full Text
View/download PDF

49. Supplementary figure legend from ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment

Author

Lamberts, Laetitia E., primary, Menke-van der Houven van Oordt, Catharina W., primary, ter Weele, Eva J., primary, Bensch, Frederike, primary, Smeenk, Michiel M., primary, Voortman, Johannes, primary, Hoekstra, Otto S., primary, Williams, Simon P., primary, Fine, Bernard M., primary, Maslyar, Daniel, primary, de Jong, Johan R., primary, Gietema, Jourik A., primary, Schröder, Carolien P., primary, Bongaerts, Alphons H.H., primary, Lub-de Hooge, Marjolijn N., primary, Verheul, Henk M.W., primary, Sanabria Bohorquez, Sandra M., primary, Glaudemans, Andor W.J.M., primary, and de Vries, Elisabeth G.E., primary

Published
2023
Full Text
View/download PDF

50. Supplementary figure 1A from ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment

Author

Lamberts, Laetitia E., primary, Menke-van der Houven van Oordt, Catharina W., primary, ter Weele, Eva J., primary, Bensch, Frederike, primary, Smeenk, Michiel M., primary, Voortman, Johannes, primary, Hoekstra, Otto S., primary, Williams, Simon P., primary, Fine, Bernard M., primary, Maslyar, Daniel, primary, de Jong, Johan R., primary, Gietema, Jourik A., primary, Schröder, Carolien P., primary, Bongaerts, Alphons H.H., primary, Lub-de Hooge, Marjolijn N., primary, Verheul, Henk M.W., primary, Sanabria Bohorquez, Sandra M., primary, Glaudemans, Andor W.J.M., primary, and de Vries, Elisabeth G.E., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results